Researchers at the University of Chicago have developed a "universal" chimeric antigen receptor (CAR) platform that offers enhanced safety, adaptability, and the potential to overcome long-standing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback